Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Human Mutation|March 6, 2003
TP53 family members and human cancersJean Bénard, Setha Douc-Rasy, Jean-Charles Ahomadegbe
Oncogene|December 14, 2004
Low expression of Wnt-5a gene is associated with high-risk neuroblastomaEtienne Blanc, Gwenaëlle Le Roux, Jean Bénard, et al.
Biochemical Pharmacology|May 15, 2002
Expression of p53-family members and associated target molecules in breast cancer cell lines in response to vincristine treatmentMuriel Vayssade, Laetitia Faridoni-Laurens, Jean Bénard, et al.
Plos One|November 22, 2013
WNT5A encodes two isoforms with distinct functions in cancersMatthieu Bauer, Jean Bénard, Terry Gaasterland, et al.
BMC Cancer|April 1, 2009
Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastomaGilda Raguénez, Annick Mühlethaler-Mottet, Roland Meier, et al.
BMC Cancer|September 4, 2010
p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastomaXénia Mergui, Marie-Line Puiffe, Dominique Valteau-Couanet, et al.
International Journal of Cancer|April 26, 2005
P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cellsMuriel Vayssade, Hedi Haddada, Laetitia Faridoni-Laurens, et al.
Molecular Oncology|October 21, 2015
WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastomaCaroline Masserot, Qingyuan Liu, Eric Nguyen, et al.
Cancer Genetics and Cytogenetics|November 19, 2003
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literatureDaniel Satgé, Sam W Moore, Charles A Stiller, et al.
Blood|September 20, 2002
Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patientsDominique Valteau-Couanet, Christophe Leboulaire, Kim Maincent, et al.
Pageof 6